The global coronavirus disease 2019 (COVID-19) will exacerbate the negative health
outcomes associated with the concurrent opioid overdose crisis in North America. COVID-19 …

Background From mid-2018, an increase in novel psychoactive substance (NPS)
benzodiazepines was noted on surveillance of the unregulated drug market around …

Introduction Existing literature is inconclusive as to whether disparities in access to health
care between men and women are mainly driven by socioeconomic or gender inequalities …

Background A cascade of care framework has been proposed to identify and address
implementation gaps in addiction medicine. Using this framework, we characterized …

Objective Adherence to opioid agonist therapy with methadone is associated with improved
clinical and community outcomes such as reductions in drug use, criminal behavior, high …

Abstract Background & Aims Despite the high burden of hepatitis C virus (HCV) infection
among people who inject drugs (PWID), uptake of interferon‐based therapies has been …

Background No effective pharmacotherapies exist for the treatment of crack cocaine use
disorders. Emerging data suggests that cannabinoids may play a role in reducing cocaine …

Background Access to health care is a crucial determinant of health. Yet, even within
settings that purport to provide universal health coverage (UHC), sex workers' experiences …

Despite a growing number of evidenced-based addiction treatments, a substantial
implementation gap in addiction medicine remains. The 'cascade of care'framework can …

Objective To assess the efficacy of slow release oral morphine (SROM) as a treatment for
opioid use disorder (OUD). Design Systematic review and meta-analysis of randomised …